301 related articles for article (PubMed ID: 34188558)
1. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.
Yamamoto T
Clin Pharmacol; 2021; 13():135-143. PubMed ID: 34188558
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
Yamamoto T
Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
[TBL] [Abstract][Full Text] [Related]
3. Pustulotic arthro-osteitis associated with palmoplantar pustulosis.
Yamamoto T
J Dermatol; 2013 Nov; 40(11):857-63. PubMed ID: 24127744
[TBL] [Abstract][Full Text] [Related]
4. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis.
Yamamoto T
Adv Otorhinolaryngol; 2011; 72():89-92. PubMed ID: 21865699
[TBL] [Abstract][Full Text] [Related]
5. Similarity and difference between palmoplantar pustulosis and pustular psoriasis.
Yamamoto T
J Dermatol; 2021 Jun; 48(6):750-760. PubMed ID: 33650702
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis.
Yamamoto T; Fukuda K; Morita A; Kimura T; Morishima H; Goto R; Zheng R; Terui T
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2318-2329. PubMed ID: 32173916
[TBL] [Abstract][Full Text] [Related]
7. Dietary habits in Japanese patients with palmoplantar pustulosis.
Serizawa N; Okazaki S; Otsuka Y; Koto M; Okabe K; Ito M; Morita T; Hoashi T; Saeki H; Abe N; Mori M; Okubo Y; Yano Y; Mitsui H; Kanda N
J Dermatol; 2021 Mar; 48(3):366-375. PubMed ID: 33404125
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of pustulotic arthro-osteitis with amoxicillin: A case report and review of the literature.
Terui H; Segawa Y; Otake E; Omori R; Tsuchiyama K; Kikuchi K; Yamasaki K; Aiba S; Asano Y
J Dermatol; 2023 Nov; 50(11):1478-1483. PubMed ID: 37269150
[TBL] [Abstract][Full Text] [Related]
9. Guselkumab improves joint pain in patients with pustulotic arthro-osteitis: A retrospective pilot study.
Ikumi N; Fujita H; Terui T
J Dermatol; 2021 Feb; 48(2):199-202. PubMed ID: 33051886
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Japanese patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: a multicenter study.
Yamamoto T; Hiraiwa T; Tobita R; Hirano H; Masuda-Kuroki K; Ishii M; Murakami M; Terui T; Okubo Y
Int J Dermatol; 2020 Apr; 59(4):441-444. PubMed ID: 31985054
[TBL] [Abstract][Full Text] [Related]
11. Utility of nailfold capillary assessment for predicting pustulotic arthro-osteitis in palmoplantar pustulosis based on a prospective cohort study.
Fukasawa T; Yamashita T; Enomoto A; Toyama S; Yoshizaki-Ogawa A; Tateishi S; Kanda H; Miyagawa K; Sato S; Yoshizaki A
J Am Acad Dermatol; 2023 Nov; 89(5):984-991. PubMed ID: 37517674
[TBL] [Abstract][Full Text] [Related]
12. Nail lesions in palmoplantar pustulosis and pustulotic arthro-osteitis impairs patients' quality of life: Suggesting new assessment tool of PPP nail lesions.
Masuda-Kuroki K; Kawakami H; Abe N; Mori M; Tobita R; Fukushi R; Hiruma J; Takeda Y; Okubo Y
J Dermatol Sci; 2022 Apr; 106(1):29-36. PubMed ID: 35307234
[TBL] [Abstract][Full Text] [Related]
13. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
Yamamoto T
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
[TBL] [Abstract][Full Text] [Related]
14. Cefcapene Pivoxil Hydrochloride Is a Potentially New Treatment for Palmoplantar Pustulosis with Pustulotic Arthro-Osteitis.
Murakami M; Masuda K; Utsunomiya R; Oda F; Namba C; Sayama K
Dermatology; 2015; 231(4):304-11. PubMed ID: 26440444
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in palmoplantar pustulosis.
Brunasso AMG; Massone C
Fac Rev; 2021; 10():62. PubMed ID: 34409425
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of pustulotic arthro-osteitis in Korea.
Kim M; Kim M; Kim JW; Kim BR; Youn SW
J Dermatol; 2022 Aug; 49(8):762-768. PubMed ID: 35510638
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients.
Takahara M; Hirata Y; Nagato T; Kishibe K; Katada A; Hayashi T; Kishibe M; Ishida-Yamamoto A; Harabuchi Y
J Dermatol; 2018 Jul; 45(7):812-823. PubMed ID: 29732605
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.
Watanabe T; Watanabe Y; Asai C; Asami M; Takamura N; Yamaguchi Y
J Dermatol; 2024 May; ():. PubMed ID: 38760982
[TBL] [Abstract][Full Text] [Related]
19. Non-bacterial vertebral osteitis as the first manifestation of pustulotic arthro-osteitis.
Ueda Y; Yokogawa N; Shimada K
Mod Rheumatol Case Rep; 2023 Jun; 7(2):488-490. PubMed ID: 36905395
[TBL] [Abstract][Full Text] [Related]
20. Guselkumab for the treatment of palmoplantar pustulosis.
Murakami M
Expert Opin Biol Ther; 2020 Aug; 20(8):841-852. PubMed ID: 32321322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
